Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer

Project: Research project

Description

Ovarian cancer is the leading cause of death in women with gynecological malignancies in the U.S., with an overall 5-year survival of
StatusActive
Effective start/end date8/1/177/31/22

Funding

  • National Institutes of Health: $504,040.00
  • National Institutes of Health: $504,040.00

Fingerprint

Genetic Therapy
Ovarian Neoplasms
Cause of Death
Survival
Neoplasms